MYELO THERAPEUTICS GMBH

BERLIN, BERLIN 10115

$2.22M
Total Contract Value
13 awards
First Award
Apr 28, 2022
Last Award
Jan 16, 2025
Business Size
other than small
CAGE Code
DP990

Top Industries (NAICS)

NAICS CodeObligationsAwards
541714$2.22M13

Contract Awards

2 awards found

75N93020C00005
Department of Health and Human Services
$219K
Sep 15, 2023

DEVELOPMENT OF MYELO001 AS AN ORALLY APPLIED MEDICAL COUNTERMEASURE FOR THE TREATMENT OF HEMATOPOIETIC ACUTE RADIATION SYNDROME

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
75N93020C00005
Department of Health and Human Services
$2.00M
Apr 28, 2022

DEVELOPMENT OF MYELO001 AS AN ORALLY APPLIED MEDICAL COUNTERMEASURE FOR THE TREATMENT OF HEMATOPOIETIC ACUTE RADIATION SYNDROME

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2022

Business Details

UEI
G1LNCHNLYXF6
CAGE Code
DP990
Address
RHEINSBERGER STR. 7
BERLIN, 10115

Parent Company

MYELO THERAPEUTICS GMBH

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov